Projects per year
Personal profile
Education
- 2008 Ph.D Rutgers UniversityPharmacology
- 1998 M.S., Institute of Biochemistry and Molecular Biology
- 1996 B.S., Department of Agriculture Chemistry, National Taiwan University
Experience
- 2018- Assiociate Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2018- Assiociate Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013-2018 Assistant Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2009-2013 Postdoc, Princeton University
Research Interests
- DNA damage
- tumor biology
- vaccine design
URL
Fingerprint
- 6 Similar Profiles
Network
Projects
- 6 Finished
-
Studies of Prostate Cancer Progression after Androgen-Deprivation Therapy and Development of Cancer Immunotherapy via Anti-Inflammation Approaches
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
Roles of Microrna96 in Tgfβ-Mediated Tumor Progression
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Roles of microRNA96 in TGF-beta-Mediated Tumor Progression(2/3)
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
-
Roles of microRNA96 in TGF-beta-Mediated Tumor Progression
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
-
TMU102-AE1-B30
4/1/14 → 12/31/16
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
Research output
-
Roles of interleukin-1 receptor antagonist in prostate cancer progression
Fan, Y. C., Lee, K. D. & Tsai, Y. C., Dec 2020, In: Biomedicines. 8, 12, p. 1-13 13 p., 602.Research output: Contribution to journal › Article › peer-review
Open Access -
Tumor-infiltrating leukocytes suppress local inflammation via interleukin-1 receptor antagonist in a syngeneic prostate cancer model
Fan, Y. C., Chen, W. Y., Lee, K. D. & Tsai, Y. C., Apr 2020, In: Biology. 9, 4, 67.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
Tsai, Y. C., Chen, W. Y., Abou-Kheir, W., Zeng, T., Yin, J. J., Bahmad, H., Lee, Y. C. & Liu, Y. N., May 1 2018, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1864, 5, p. 1717-1727 11 p.Research output: Contribution to journal › Article › peer-review
16 Citations (Scopus) -
A synergistic anti-cancer effect of troglitazone and lovastatin in a human anaplastic thyroid cancer cell line and in a mouse xenograft model
Zhong, W. B., Tsai, Y. C., Chin, L. H., Tseng, J. H., Tang, L. W., Horng, S., Fan, Y. C. & Hsu, S. P., Jul 1 2018, In: International Journal of Molecular Sciences. 19, 7, 1834.Research output: Contribution to journal › Article › peer-review
8 Citations (Scopus) -
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. C., Zeng, T., Abou-Kheir, W., Yeh, H. L., Yin, J. J., Lee, Y. C., Chen, W. Y. & Liu, Y. N., Feb 19 2018, In: Molecular Cancer. 17, 1, 42.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)